MEI PHARMA INC (MEIP) Stock News

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining

Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

MEI Pharma Reports Fiscal Year End 2024 Cash Position

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

MEI Pharma to Consider Strategic Alternatives

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024

MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024.

MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips MEI Pharma (NASDAQ:MEIP) just reported results for the third quarter of 2024.ME...

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

MEI Pharma files for $100M mixed shelf (NASDAQ:MEIP)

MEI Pharma files prospectus for mixed securities shelf offering of up to $100M.

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

MEI Pharma Recommends Stockholders Not to Consent

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Infinity Pharmaceuticals reportedly files for Chapter 11 (OTCMKTS:INFI)

Infinity Pharmaceuticals (INFI) has reportedly filed for bankruptcy in the wake of the termination of its merger deal with MEI Pharma.

MEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actions

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023